Familial Mediterranean fever in Germany: Clinical presentation and amyloidosis risk

Scandinavian Journal of Rheumatology

Volumn 42, Issue 1, 2013, Pages 52-58

  Ebrahimi Fakhari, D ^a   Schonland S O ^a   Hegenbart, U ^a   Lohse, P ^b   Beimler, J ^a   Wahlster, L ^a   Ho, A D ^a   Lorenz, H M ^a   Blank, N ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYLOIDOSIS; ARTHRALGIA; ARTHRITIS; ARTICLE; DISEASE PREDISPOSITION; ERYSIPELAS LIKE ERYTHEMA; ERYTHEMA; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FEVER; GENE MUTATION; GENETIC ANALYSIS; GERMANY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PERITONITIS; PLEURISY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VASCULITIS;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AMYLOIDOSIS; CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; GERMANY; HUMANS; MIDDLE AGED; PERITONITIS; POINT MUTATION; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSIENTS AND MIGRANTS; YOUNG ADULT;

EID: 84872872360     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2012.714796     Document Type: Article

References (49)

1. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 1967;43:227-53
2. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40:1879-85 (Pubitemid 27452541)
3. Siegal S. Benign paroxysmal peritonitis. Ann Intern Med 1945; 23:1-21
4. Ben-Chetrit E, Touitou I. Familial Mediterranean fever in the world. Arthritis Rheum 2009;61:1447-53
5. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, et al. Familial Mediterranean fever (FMF) in Turkey: Results of a nationwide multicenter study. Medicine 2005;84:1-11 (Pubitemid 40130180)
6. Tsuchiya-Suzuki A, YazakiM, Nakamura A, Yamazaki K, Agematsu K, Matsuda M, et al. Clinical and genetic features of familial Mediterranean fever in Japan. J Rheumatol 2009;36: 1671-6
7. Ozen S, Aktay N, Lainka E, Duzova A, Bakkaloglu A, Kallinich T. Disease severity in children and adolescents with familial Mediterranean fever: A comparative study to explore environmental effects on a monogenic disease. Ann Rheum Dis 2009;68:246-8
8. Tchernitchko D, Moutereau S, Legendre M, Delahaye A, Cazeneuve C, Lacombe C, et al. MEFV analysis is of particularly weak diagnostic value for recurrent fevers in Western European Caucasian patients. Arthritis Rheum 2005;52:3603-5 (Pubitemid 41612230)
9. Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, et al. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum 2007;56:1706-12 (Pubitemid 46764102)
10. Kuempfel T, Gerdes LA, Wacker T, Blaschek A, Havla J, Krumbholz M, et al. Familial Mediterranean fever-Associated mutation pyrin E148Q as a potential risk factor for multiple sclerosis. Mult Scler. Published online: 15 February 2012. doi:10.1177/1352458512437813
11. Heller H, Sohar E, Gafni J, Heller J. Amyloidosis in familial Mediterranean fever An independent genetically determined character. Arch Intern Med 1961;107:539-50
12. Livneh A, Zemer D, Langevitz P, Laor A, Sohar E, Pras M. Colchicine treatment of AA amyloidosis of familial Mediterranean fever An analysis of factors affecting outcome. Arthritis Rheum 1994;37:1804-11 (Pubitemid 24371884)
13. Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986;314:1001-5 (Pubitemid 16138694)
14. Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med 2007;356:2361-71 (Pubitemid 46883770)
15. Zemer D, Livneh A, Danon YL, Pras M, Sohar E. Long-Term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum 1991;34:973-7
16. Bernot A, Clepet C, Dasilva C, Devaud C, Petit JL, Caloustian C, et al. French FMF consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997;17:25-31 (Pubitemid 27377528)
17. Aksentijevich I, Centola M, Deng Z, Sood R, Balow JE, Wood G, et al. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997;90:797-807 (Pubitemid 27357970)
18. Infevers. The Registry of Hereditary Auto-inflammatory Disorders Mutations http://fmf.igh.cnrs.fr//ISSAID/infevers, (accessed 12 September 2012
19. Chae JJ, Aksentijevich I, Kastner DL. Advances in the understanding of familialMediterranean fever and possibilities for targeted therapy. Br J Haematol 2009;146:467-78
20. Chae JJ, Cho YH, Lee GS, Cheng J, Liu PP, Feigenbaum L, et al. Gain-of-function Pyrin mutations induce NLRP3 proteinindependent interleukin-1β activation and severe autoinflammation in mice. Immunity 2011;34:755-68
21. Shohat M, Halpern GJ. Familial Mediterranean fever - A review. Genet Med 2011;13:487-98
22. Majeed HA, El-Shanti H, Al-Khateeb MS, Rabaiha ZA. Genotype/ phenotype correlations in Arab patients with famili
23. Shinar Y, Livneh A, Langevitz P, Zaks N, Aksentijevich I, Koziol DE, et al. Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever. J Rheumatol 2000;27:1703-7 (Pubitemid 30462815)
24. Brik R, Shinawi M, Kepten I, Berant M, Gershoni-Baruch R. Familial Mediterranean fever: Clinical and genetic characterization in a mixed pediatric population of Jewish and Arab patients. Pediatrics 1999;103:e70
25. Cazeneuve C, Sarkisian T, Pecheux C, Dervichian M, Nedelec B, Reinert P, et al. MEFV-gene analysis in Armenian patients with familial Mediterranean fever: Diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype - genetic and therapeutic implications. Am J Hum Genet 1999;65:88-97 (Pubitemid 30470452)
26. Dewalle M, Domingo C, Rozenbaum M, Ben-Chetrit E, Cattan D, Bernot A, et al. Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). Eur J Hum Genet 1998;6:95-7 (Pubitemid 28101703)
27. Shohat M, Magal N, Shohat T, Chen X, Dagan T, Mimouni A, et al. Phenotype-genotype correlation in familial Mediterranean fever: Evidence for an association between Met694Val and amyloidosis. Eur J Hum Genet 1999;7:287-92 (Pubitemid 29213734)
28. Pasa S, Altintas A, Devecioglu B, Cil T,Danis R, Isi H, et al. Familial Mediterranean fever gene mutations in the southeastern region of Turkey and their phenotypical features. Amyloid 2008;15:49-53 (Pubitemid 351238494)
29. Mansour I, Delague V, Cazeneuve C, Dode C, Chouery E, Pecheux C, et al. Familial Mediterranean fever in Lebanon: Mutation spectrum, evidence for cases in Maronites, Greek orthodoxes, Greek catholics, Syriacs and Chiites and for an association between amyloidosis and M694V and M694I mutations. Eur J Hum Genet 2001;9:51-5 (Pubitemid 32124434)
30. Livneh A, Langevitz P, Shinar Y, Zaks N, Kastner DL, Pras M, et al. MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid 1999;6:1-6 (Pubitemid 29249929)
31. Balci B, Tinaztepe K, Yilmaz E, Gucer S, Ozen S, Topaloglu R, et al. MEFV gene mutations in familial Mediterranean fever phenotype II patients with renal amyloidosis in childhood: A retrospective clinicopathological and molecular study. Nephrol Dial Transplant 2002;17:1921-3 (Pubitemid 35277088)
32. Yalcinkaya F, Cakar N, Misirlioglu M, Tumer N, Akar N, Tekin M, et al. Genotype-phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: Evidence for mutationindependent amyloidosis. Rheumatology 2000;39:67-72 (Pubitemid 30095409)
33. Livneh A, Langevitz P, Zemer D, Padeh S, Migdal A, Sohar E, et al. The changing face of familial Mediterranean fever. Semin Arthritis Rheum 1996;26:612-27 (Pubitemid 27024198)
34. Pras E, Livneh A, Balow JE Jr, Kastner DL, Pras M, Langevitz P. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 1998;75:216-19 (Pubitemid 28034505)
35. Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R, et al. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine 1998;77:268-97 (Pubitemid 28376140)
36. Fragouli E, Eliopoulos E, Petraki E, Sidiropoulos P, Aksentijevich I, Galanakis E, et al. Familial Mediterranean fever in Crete: A genetic and structural biological approach in a population of 'intermediate risk'. Clin Genet 2008;73:152-9
37. La Regina M, Nucera G, Diaco M, Procopio A, Gasbarrini G, Notarnicola C, et al. Familial Mediterranean fever is no longer a rare disease in Italy. Eur J Hum Genet 2003;11:50-6 (Pubitemid 36175783)
38. Barakat MH, Karnik AM, Majeed HW, el-Sobki NI, Fenech FF. Familial Mediterranean fever (recurrent hereditary polyserositis) in Arabs - A study of 175 patients and review of the literature. Q J Med 1986;60:837-47 (Pubitemid 17169382)
39. Moradian MM, Sarkisian T, Ajrapetyan H, Avanesian N. Genotype-phenotype studies in a large cohort of Armenian patients with familial Mediterranean fever suggest clinical disease with heterozygous MEFV mutations. J Hum Genet 2010;55:389-93
40. Aksu K, Keser G. Coexistence of vasculitides with familial Mediterranean fever. Rheumatol Int 2011;31:1263-74
41. Tamir N, Langevitz P, Zemer D, Pras E, Shinar Y, Padeh S, et al. Late-onset familial Mediterranean fever (FMF): A subset with distinct clinical, demographic, and molecular genetic characteristics. Am J Med Genet 1999;87:30-5 (Pubitemid 29522058)
42. Cefle A, Kamali S, Sayarlioglu M, Inanc M, Ocal L, Aral O, et al. A comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis. Rheumatol Int 2005; 25:442-6 (Pubitemid 41186913)
43. Cazeneuve C, Ajrapetyan H, Papin S, Roudot-Thoraval F, Genevieve D, Mndjoyan E, et al. Identification of MEFVindependent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 2000;67:1136-43
44. Soylemezoglu O, Arga M, Fidan K, Gonen S, Emeksiz HC, Hasanoglu E, et al. Unresponsiveness to colchicine therapy in patients with familial Mediterranean fever homozygous for the M694V mutation. J Rheumatol 2010;37:182-9
45. Yigit S, Bagci H, Ozkaya O, Ozdamar K, Cengiz K, Akpolat T. MEFV mutations in patients with familial Mediterranean fever in the Black Sea region of Turkey: Samsun experience [corrected]. J Rheumatol 2008;35:106-13
46. Kallinich T, Haffner D, Niehues T, Huss K, Lainka E, Neudorf U, et al. Colchicine use in children and adolescents with familial Mediterranean fever: Literature review and consensus statement. Pediatrics 2007;119:e474-83 (Pubitemid 46397797)
47. Ben-Chetrit E, Ozdiogan H. Non-response to colchicine in FMF -definition, causes and suggested solutions. Editorial. Clin Exp Rheumatol 2008;26:S49-51
48. Mor A, Pillinger MH, Kishimoto M, Abeles AM, Livneh A. Familial Mediterranean fever successfully treated with etanercept. J Clin Rheumatol 2007;13:38-40 (Pubitemid 46213843)
49. Meinzer U, Quartier P, Alexandra JF, Hentgen V, Retornaz F, Kone-Paut I. Interleukin-1 targeting drugs in familial Mediterranean fever: A case series and a review of the literature. Semin Arthritis Rheum 2011;41:265-71